GlassScriptPhysician profile
Julio Chong
NPI 1881012722
$35,726.92
in general payments reported to CMS, 2019-2025
41 companies · $2,635 in 2025
The $2,635 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $1,564 · 2021: $856 · 2022: $1,985 · 2023: $865 · 2024: $986 · 2025: $2,635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,372 · Consulting Fee: $600 · Travel and Lodging: $449 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,371.91 |
| Consulting Fee | $600.00 |
| Travel and Lodging | $449.02 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $29,436.15 | 2019-2025 | General - Kidney Stone Disease, Lumenis Pulse 100h, Lithovue |
| Teleflex LLC | $1,843.70 | 2021-2025 | Urolift |
| Medtronic, INC. | $600.00 | 2025 | |
| Calyxo, INC. | $588.77 | 2023-2025 | Cvac Aspiration System |
| Janssen Biotech, INC. | $368.26 | 2021-2025 | Erleada |
| Astellas Pharma US INC | $284.13 | 2020-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $276.62 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $213.77 | 2019-2025 | |
| Karl Storz Endoscopy-America | $172.15 | 2019-2020 | |
| Antares Pharma, INC. | $168.26 | 2020-2025 | Xyosted |
| Abbvie INC. | $153.72 | 2021-2025 | Botox, Lupron Depot |
| Cook Medical LLC | $142.94 | 2020 | |
| Myriad Genetic Laboratories, INC. | $132.86 | 2023 | Prolaris |
| Endo Pharmaceuticals INC. | $131.98 | 2020-2023 | Aveed, Edex, Xiaflex |
| Travere Therapeutics, INC. | $131.49 | 2019 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $100.45 | 2023-2025 | Itind System, Shockpulse |
| Ferring Pharmaceuticals INC. | $97.86 | 2019-2025 | Adstiladrin |
| Axonics, INC. | $85.76 | 2022-2024 | Axonics, Bulkamid |
| Myovant Sciences INC. | $83.90 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $77.39 | 2023-2024 | |
| Convatec INC. | $77.20 | 2021-2024 | |
| Telix Pharmaceuticals | $58.28 | 2023-2024 | Illuccix |
| Progenics Pharmaceuticals, INC. | $52.49 | 2025 | |
| Novo Nordisk INC | $52.27 | 2023-2025 | Rivfloza |
| Laborie Medical Technologies Corp. | $41.27 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Blue Earth Diagnostics | $38.54 | 2019 | |
| 180 Medical, INC. | $32.08 | 2025 | Gentlecath |
| Baxter Healthcare | $26.29 | 2019 | |
| Immunitybio, INC. | $23.47 | 2024 | |
| Alnylam Pharmaceuticals INC. | $23.34 | 2023 | Oxlumo |
| Astrazeneca Pharmaceuticals LP | $23.12 | 2023 | Lynparza |
| C. R. Bard, INC. & Subsidiaries | $22.55 | 2023 | Bard Urinary Drainage Bag |
| Urovant Sciences INC | $22.46 | 2022 | |
| Coloplast Corp | $20.74 | 2023 | Speedicath |
| Steris Corporation | $20.58 | 2024 | |
| Becton, Dickinson and Company | $20.52 | 2023 | Bard Urinary Drainage Bag |
| Janssen Scientific Affairs, LLC | $20.12 | 2019 | |
| Dendreon Pharmaceuticals LLC | $18.13 | 2024 | Provenge |
| Abc Home Medical Supply, INC. | $15.19 | 2025 | |
| Dentsply Ih Ab | $14.49 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.63 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julio Chong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.